CCM
INO icon

Covington Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Covington Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Hold
83
– – ﹤0.01% 1052
2022
Q2 		$2K Buy
+83
New +$2.34K ﹤0.01% 992

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Covington Capital Management's INO Position: Q3 2022 in Review

Covington Capital Management held its Inovio Pharmaceuticals (INO) position steady in Q3 2022 at 83 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Covington Capital Management first reported a position in INO in Q2 2022 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold INO as of Q3 2022.

  • Covington Capital Management held 83 shares of Inovio Pharmaceuticals worth $2K as of Q3 2022.
  • Covington Capital Management left its Inovio Pharmaceuticals share count unchanged in Q3 2022.
  • Inovio Pharmaceuticals made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #1052 holding.
  • Covington Capital Management first reported a position in Inovio Pharmaceuticals in Q2 2022 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.